Background mucosal inflammation affects colorectal cancer prognosis in ulcerative colitis: a nationwide, multicenter study
Open Access
- 3 December 2025
- journal article
- Published by Oxford University Press (OUP) in Journal of Crohn's and Colitis
- Vol. 20 (2)
Abstract
Background and aims: Chronic background mucosal inflammation contributes to colorectal cancer (CRC) development in ulcerative colitis (UC), but its prognostic impact is unclear. We evaluated whether background mucosal inflammation documented at cancer diagnosis is associated with oncologic outcomes. Methods: This retrospective study analyzed 1189 UC patients diagnosed with CRC using a nationwide, multicenter database in Japan. Patients were classified as CRC within the UC-involved area (within-area) or outside the UC-involved area (outside-area), based on tumor location relative to the UC disease extent documented endoscopically at cancer diagnosis. The primary end point was 5-year recurrence-free survival (RFS), and the secondary end point was 5-year cancer-specific survival (CSS). In within-area cases, inflammation severity was assessed using the Mayo Endoscopic Score (MES), stratified as Inactive, Mild–Moderate, and Severe. Results: Of the 723 eligible patients, 683 had within-area and 40 outside-area CRC. Five-year RFS was significantly lower in within-area than outside-area CRCs (75.1% vs 87.6%, P = 0.022). Multivariable Cox regression analysis of RFS revealed this classification as an independent prognostic factor (hazard ratio = 2.99, 95% confidence interval: 1.09-8.18, P = 0.030). A significant difference was also observed in 5-year CSS (P = 0.038). Among within-area cases, higher MES was associated with stepwise declines in RFS (P = 0.150), and a similar, statistically significant gradient in CSS (P = 0.048). Conclusions: Background mucosal inflammation at cancer diagnosis is associated with significantly worse prognosis of CRC in UC patients. Systematic endoscopic assessment at cancer diagnosis may aid prognostic stratification and inform management.Keywords
This publication has 30 references indexed in Scilit:
- Clinical features and oncological outcomes of intestinal cancers associated with ulcerative colitis and Crohn’s diseaseJournal of Gastroenterology, 2022
- Colorectal cancer in ulcerative colitis: a Scandinavian population-based cohort studyThe Lancet, 2020
- Impact of mucosal inflammation on risk of colorectal neoplasia in patients with ulcerative colitis: a systematic review and meta-analysisGastrointestinal Endoscopy, 2017
- Forty-Year Analysis of Colonoscopic Surveillance Program for Neoplasia in Ulcerative Colitis: An Updated OverviewAmerican Journal of Gastroenterology, 2015
- Colorectal cancer in inflammatory bowel disease: Results of the 3rd ECCO pathogenesis scientific workshop (I)Journal of Crohn's and Colitis, 2014
- The risk of colorectal cancer in patients with inflammatory bowel diseases in Finland: A follow-up of 20yearsJournal of Crohn's and Colitis, 2013
- European consensus on the histopathology of inflammatory bowel diseaseJournal of Crohn's and Colitis, 2013
- Risk of Colorectal Cancer in Patients With Ulcerative Colitis: A Meta-analysis of Population-Based Cohort StudiesClinical Gastroenterology and Hepatology, 2012
- Immunity, Inflammation, and CancerCell, 2010
- Cancer-related inflammationNature, 2008